Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers. (Q40483409)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Abigail L. Gilbert

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Kanneboyina Nagaraju

10

object named as

Kanneboyina Nagaraju

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Beth L. Thurberg

5

object named as

Beth L Thurberg

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

8

object named as

John J Hopwood

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Robert J. Mattaliano

6

object named as

Robert J Mattaliano

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Nina Raben

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Tokiko Fukuda

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Deborah de Jong

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Kunio Nagashima

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Paul H Plotz

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 January 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Molecular Therapy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

48-56

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585405%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Identification of two subtypes of infantile acid maltase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Mannose 6-phosphate receptors in sorting and transport of lysosomal enzymes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Protein transport from the secretory to the endocytic pathway in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Mannose 6-phosphate receptors: new twists in the tale

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Expression and routeing of human lysosomal alpha-glucosidase in transiently transfected mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Recombinant human alpha-glucosidase from rabbit milk in Pompe patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Enzyme replacement therapy in the mouse model of Pompe disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Conditional tissue-specific expression of the acid alpha-glucosidase (GAA) gene in the GAA knockout mice: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Induction of tolerance to a recombinant human enzyme, acid alpha-glucosidase, in enzyme deficient knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Lysosomal storage diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Receptor-mediated uptake of acid alpha-glucosidase corrects lysosomal glycogen storage in cultured skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Retroviral transfer of acid alpha-glucosidase cDNA to enzyme-deficient myoblasts results in phenotypic spread of the genotypic correction by both secretion and fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Long-term correction of glycogen storage disease type II with a hybrid Ad-AAV vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Efficacy of gene therapy for a prototypical lysosomal storage disease (GSD-II) is critically dependent on vector dose, transgene promoter, and the tissues targeted for vector transduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Long-term efficacy after [E1-, polymerase-] adenovirus-mediated transfer of human acid-alpha-glucosidase gene into glycogen storage disease type II knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Human acid alpha-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Clathrin-coated vesicle formation and protein sorting: an integrated process

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Biological basket weaving: formation and function of clathrin-coated vesicles

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Clathrin adaptors really adapt

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Regulated portals of entry into the cell

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Molecular architecture and functional model of the endocytic AP2 complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Adaptor-related proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Clathrin-mediated endocytosis in AP-2-depleted cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Toward and beyond lysosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Autophagy: a regulated bulk degradation process inside cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

The autophagic and endocytic pathways converge at the nascent autophagic vacuoles

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

The convergent point of the endocytic and autophagic pathways in leydig cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Autophagic vacuolar myopathies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Myopathy due to juvenile acid maltase deficiency affecting exclusively the type I fibres

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

The adult form of acid maltase (alpha-1,4-glucosidase) deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Transgenic animals with inducible, targeted gene expression in brain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Surprises of genetic engineering: a possible model of polyglucosan body disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.017

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40483409&oldid=1883291949"